[Date Prev][Date Next][Thread Prev][Thread Next]
Author IndexDate IndexThread Index

[RegAffairs]Re: Black eye for US Pharma Industry

Dear Mike,
I am surprised that you are surprised!!!!
Whether the report is 100% accurate or not will be revealed by 
others. All I can say is that auditing companies in Europe and Asia 
the thing that I find the most surprising is that in a single 
jurisdiction you can find one factory which is really pretty good and 
they are complaining that they recently had an inspection and they 
had to deal with some minor point about calibration for example. You 
travel a few hundred kilometers and walk into a plant which would be 
acceptable for car repairs [OK so a slight exaggeration but not much].

The report quotes paint-I have twice seen walls being knocked down 
and rebuilt while production carried on [tablet hardness was probably 
OK from the cement powder!].

Now I am sure many of us have our own personal horror stories-so why 
am I writing this? Because I really feel that there are indeed two 
worlds out there. On the one hand regulators are talking about QbD, 
design space, risk management and ICH Q10-all admirable things in 
their own right. On the other hand there are still factories as 
described in the article who probably think that painting the 
facility while manufacturing is exactly what is meant by design 
space!!!


All the best

Malcolm Ross
Generapharm-Training and Consultancy
Basel-CH
m.ross@generapharm.eu


[Date Prev][Date Next][Thread Prev][Thread Next]
Author IndexDate IndexThread Index